Compulsory Licensing: Is it a non-starter or a failure of the nation?
Milind Sathe, Author, Compulsory Licensing in Knowledge Economy, in this article, elucidates on aspects of CL that are globally…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
International politics and IPR
Dr R Saha, Senior Adviser, CII elaborates on the robustness of India’s IPR regime particularly related to laws and the judicial…
De-addiction with technology
On the occasion of World Mental Health Day, October 10, Dr Navin Saxena, Chairman, Rusan Pharma opines that substance abuse/…
Invictus Oncology to present data on IO-125 at Breast Cancer Symposium
IO-125, a novel supramolecular platinum chemotherapy, is being developed in Triple-Negative Breast Cancer (TNBC) Invictus…
Pharma market overview: The expanding role of India and Indian companies
Maneesh Chandra, India Business Consulting Head - ZS Associates, elaborates on how the evolving global and domestic market…
Antisense RNAi therapeutics deals value approached $5.6 billion in landmark 2014: GlobalData
The figure almost triple that of the previous year, with just over $1.9 billion raised from 62 deals in 2013
Online Pharmacies Revolution In The Making?
Online pharmacy is a concept that is still at a nascent stage in India, yet it seems to have a huge potential for growth.…
‘We manage cash flows better’
MyCFO helps companies to manage their cashflow process and also helps in operating cycle of distributor/ dealer linkages,…
Pancreatic cancer treatment pipeline dominated by early-stage development Research
The high level of first-in-class development in pancreatic cancer therapeutics is a promising sign of the industry seeking…
Anti-hypertensive therapeutics market in APAC to touch $20 bn by 2021: GBI Research
Modest growth will be primarily due to lack of hypertension awareness, leading to low diagnosis and treatment rates
How placebomes could change clinical trial design
Analysing recent preliminary research on the 'placebome' - a set of genes that trigger some placebo responders to respond to the…
Global CRO deals value rockets to almost $10 billion between Jan- April 2015: GBI Research
Struggling to balance R&D expenditure and profitability, pharma companies are outsourcing R&D and clinical trial…
Recent drug approvals to boost Parkinson’s disease therapeutics market: GlobalData
Treatment market value across eight major countries to reach $4.7 billion by 2022
Global gene therapy deals sky-rocketed to nearly $5 bn in 2014: GlobalData
M&A typically low in gene therapy field as technology remains highly experimental and majority of products are in early-stage…
FTP 2015-2020 A welcome move
The Ministry of Commerce, Government of India has released the new Foreign Trade Policy for 2015-2020, to be amended from June 30,…
‘Significant improvements have occurred in medicine quality in Asia’
The US Pharmacopeial Convention (USP), recently brought together national medicines control laboratory officials for a workshop in…
ReDefining NSQ
India has highest number of US FDA approved manufacturing facilities outside the US and yet the Indian pharma industry faces…
Competence in clinical research
Dr Martin Robinson, Executive Vice President and International Academy of Clinical Research (IAOCR) Ambassador, talks about…
One year of Modi govt: India Inc, be patient
Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon, remains optimistic about her expectations from the Modi government…
UCPMP: ‘Code’ word for pharma industry
The Uniform Code of Pharmaceutical Marketing Practices (UCPMP), launched by the Department of Pharmaceuticals (DoP) has not roused…